Satellos Bioscience Stock Performance
| MSCLF Stock | USD 0.53 0.05 10.42% |
Satellos Bioscience has a performance score of 2 on a scale of 0 to 100. The entity has a beta of -0.0776, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Satellos Bioscience are expected to decrease at a much lower rate. During the bear market, Satellos Bioscience is likely to outperform the market. Satellos Bioscience right now has a risk of 3.99%. Please validate Satellos Bioscience value at risk and the relationship between the expected short fall and price action indicator , to decide if Satellos Bioscience will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Satellos Bioscience are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Satellos Bioscience may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more
| Begin Period Cash Flow | 717.5 K | |
| Total Cashflows From Investing Activities | 1.7 M |
Satellos |
Satellos Bioscience Relative Risk vs. Return Landscape
If you would invest 52.00 in Satellos Bioscience on September 27, 2025 and sell it today you would earn a total of 1.00 from holding Satellos Bioscience or generate 1.92% return on investment over 90 days. Satellos Bioscience is currently producing 0.1077% returns and takes up 3.986% volatility of returns over 90 trading days. Put another way, 35% of traded otc stocks are less volatile than Satellos, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Satellos Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Satellos Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Satellos Bioscience, and traders can use it to determine the average amount a Satellos Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.027
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | MSCLF | Huge Risk |
| Negative Returns |
Based on monthly moving average Satellos Bioscience is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Satellos Bioscience by adding it to a well-diversified portfolio.
Satellos Bioscience Fundamentals Growth
Satellos OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Satellos Bioscience, and Satellos Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Satellos OTC Stock performance.
| Return On Equity | -0.86 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 7.17 M | |||
| Shares Outstanding | 41.8 M | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 295.34 X | |||
| EBITDA | (4.49 M) | |||
| Cash And Equivalents | 1.93 M | |||
| Cash Per Share | 0.06 X | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (5.03 M) | |||
| Earnings Per Share | (0.47) X | |||
| Total Asset | 12.59 M | |||
About Satellos Bioscience Performance
By analyzing Satellos Bioscience's fundamental ratios, stakeholders can gain valuable insights into Satellos Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Satellos Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Satellos Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Satellos Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Satellos Bioscience performance evaluation
Checking the ongoing alerts about Satellos Bioscience for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Satellos Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Satellos Bioscience has some characteristics of a very speculative penny stock | |
| Satellos Bioscience had very high historical volatility over the last 90 days | |
| Satellos Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (793.97 K). | |
| Satellos Bioscience has accumulated about 1.93 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. |
- Analyzing Satellos Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Satellos Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Satellos Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Satellos Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Satellos Bioscience's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Satellos Bioscience's otc stock. These opinions can provide insight into Satellos Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Satellos OTC Stock analysis
When running Satellos Bioscience's price analysis, check to measure Satellos Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Satellos Bioscience is operating at the current time. Most of Satellos Bioscience's value examination focuses on studying past and present price action to predict the probability of Satellos Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Satellos Bioscience's price. Additionally, you may evaluate how the addition of Satellos Bioscience to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |